United States · FDA National Drug Code directory

Docetaxel

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72078-086_3eb46e06-aabe-42b6-ac06-057bca6e0d38
Product NDC
72078-086
Form
INJECTION, SOLUTION
Composition / generic term
DOCETAXEL ANHYDROUS
Labeler
Mylan Institutional LLC
Marketing category
ANDA
Marketing start / end (source format)
20220803
Source listing expiry
20271231

Source-listed ingredients

  • DOCETAXEL ANHYDROUS — 10 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

Package details are not available in this snapshot.

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →